Nigerian Breast Cancer Risk-Reduction Study

NCT ID: NCT05834933

Last Updated: 2023-08-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

719 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-02-13

Study Completion Date

2021-10-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will be a randomized controlled trial. The aim of the study is to determine the Breast Cancer (BC) risk and to evaluate the effect of BC risk counseling on lifestyle changes and adherence to risk-reduction practices among first-degree female relatives of BC patients in South-West Nigeria. This study's research questions are:

* What are the Nigeria Breast Cancer Study (NBCS) and Gail models estimates of the BC risk of first-degree female relatives of BC patients in South-West, Nigeria?
* What are the effects of BC risk assessment and counseling on adherence to breast screening recommendations among first-degree female relatives of BC patients in South-West, Nigeria?
* What are the effects of BC risk assessment and counseling on adherence to lifestyle risk reduction recommendations among first-degree female relatives of BC patients in South-West, Nigeria?
* What is the knowledge, attitudes, and perception of first-degree female relatives of BC patients in South-West Nigeria towards genetic testing and BC etiology?
* What factors predict breast screening among first-degree female relatives of BC patients in South-West Nigeria?
* What factors predict the time to first BC screening (post-intervention) among first-degree female relatives of BC patients in South-West Nigeria?

Participants will be randomized into the control arm (standard care) and intervention arms of the study. The intervention arm of the study will have a BC risk assessment followed by individualized BC risk counseling. In addition, the intervention arm will receive BC awareness and MammaCare® BSE training. The control arm will receive only standard care comprising BC awareness and MammaCare® BSE training. Both study arms will receive BC screening recommendations and lifestyle modification recommendations.

We hope that the BC risk counseling will improve BC screening practices and modification of risk behaviors and this hypothesis will be tested.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Risk Reduction Behavior Breast Cancer Health Behavior Health Care Utilization Health Knowledge, Attitudes, Practice

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

DOUBLE

Participants Caregivers
Participants, Data collectors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard care (SC)

Participants received one-on-one breast cancer awareness education; one-on-one monthly Breast Self-Examination (BSE) training; general breast cancer screening recommendations; and general lifestyle modification recommendations

Group Type NO_INTERVENTION

No interventions assigned to this group

SC + Risk assessment and counselling

Participants received Standard care as described in the SC arm above in addition to individualized breast cancer risk assessment, individualized breast cancer risk counseling, and lifestyle risk reduction recommendations

Group Type EXPERIMENTAL

Individualized breast cancer risk assessment

Intervention Type BEHAVIORAL

Individualized breast cancer risk assessment: The Nigerian Breast Cancer Study (NBCS) absolute risk prediction model was used to predict the 5-year and lifetime breast cancer risks of the participants. The model utilized individual breast cancer risk factors.

Individualized breast cancer risk counselling

Intervention Type BEHAVIORAL

Individualized breast cancer risk counselling: The Principal Investigator (PI) and other trained risk counsellors discussed the results of the NBCS risk prediction model with participants and counselled them about the risk of developing breast cancer. The

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Individualized breast cancer risk assessment

Individualized breast cancer risk assessment: The Nigerian Breast Cancer Study (NBCS) absolute risk prediction model was used to predict the 5-year and lifetime breast cancer risks of the participants. The model utilized individual breast cancer risk factors.

Intervention Type BEHAVIORAL

Individualized breast cancer risk counselling

Individualized breast cancer risk counselling: The Principal Investigator (PI) and other trained risk counsellors discussed the results of the NBCS risk prediction model with participants and counselled them about the risk of developing breast cancer. The

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Risk assessment Counseling

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. First-degree female relatives of histologically diagnosed BC patients in the study sites
2. Women aged 20 to 75 years of age
3. Willingness to be contacted after six months for follow-up

Exclusion Criteria

1. Personal history of BC
2. Previous exposure to breast cancer risk assessment and counselling
3. Absence of intact breasts
Minimum Eligible Age

20 Years

Maximum Eligible Age

75 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lagos State University Teaching Hospital (LASUTH)

UNKNOWN

Sponsor Role collaborator

Obafemi Awolowo University Teaching Hospital

OTHER

Sponsor Role collaborator

Lagos University Teaching Hospital (LUTH)

UNKNOWN

Sponsor Role collaborator

University College Hospital, Ibadan

OTHER

Sponsor Role collaborator

University of Ibadan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Agwai Celia Imaria

Epidemiologist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

OLADOSUN A OJENGBEDE, FMCOG, FWACS, FICS, M.B.B.S

Role: PRINCIPAL_INVESTIGATOR

CENTER FOR POPULATION AND REPRODUCTIVE HEALTH (CPRH), UNIVERSITY COLLEGE HOSPITAL, IBADAN

OLADELE O.O KALE, B.A, M.B, B.Ch, B.A.O

Role: PRINCIPAL_INVESTIGATOR

University of Ibadan

IKEOLUWAPO O. AJAYI, MBBS; PhD

Role: PRINCIPAL_INVESTIGATOR

University of Ibadan

CELIA IMARIA AGWAI, M.P.H; Ph.D.

Role: PRINCIPAL_INVESTIGATOR

University of Ibadan

DEZHENG HUO, PhD

Role: STUDY_DIRECTOR

University of Chicago

OLUFUNMILAYO OLOPADE, M.D., F.A.C.P

Role: STUDY_CHAIR

University of Chicago

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Obafemi Awolowo University Teaching Hospital Complex (OAUTHC)

Ile-Ife, Osun State, Nigeria

Site Status

University College Hospital (UCH)

Ibadan, Oyo State, Nigeria

Site Status

Lagos State University Teaching Hospital (LASUTH)

Lagos, , Nigeria

Site Status

Lagos University Teaching Hospital (LUTH)

Lagos, , Nigeria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Nigeria

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NHREC/05/01/2008a

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Breast Cancer Prevention Education
NCT01299623 COMPLETED NA